Drugs / Levodopa-carbidopa intestinal gel
last change Mar 2015 re-read 3 minutes ago

Levodopa-carbidopa intestinal gel

Developed for
Parkinson disease
Investigated by
AbbVie

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01960842 Oct 2013 → Mar 2015 Parkinson disease AbbVie Completed Met primary

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Levodopa-carbidopa intestinal gel ClinicalTrials.gov intervention name — accepted as the source's own label NCT01960842 ↗
Route Other “via the N-J tube” NCT01960842 ↗